^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Combotox (Imtox19/Imtox22)

    i
    Other names: Imtox19/Imtox22, deglycosylated ricin A chain-conjugated anti-CD19/anti-CD22 immunotoxins
    Associations

    News

    Trials
    Company:
    Abiogen, Montefiore Medical Center, National Cancer Institute
    Drug class:
    CD19 inhibitor, Protein synthesis inhibitor, CD22 inhibitor
    Related drugs:
    Associations

    News

    Trials
    3years
    Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia (clinicaltrials.gov)
    P1, N=10, Completed, Albert Einstein College of Medicine | Recruiting --> Completed | N=20 --> 10
    Trial completion • Enrollment change
    |
    CD19 (CD19 Molecule) • CD22 (CD22 Molecule)
    |
    CD19 expression
    |
    Combotox (Imtox19/Imtox22)